series-b
Stage
3
Investors
About
ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that prevent Fas-mediated cell death to treat retinal diseases and preserve vision.
Explore ONL Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.